Monitoring is the cornerstone of safe, optimized GLP-1 therapy. Baseline and follow-up laboratory testing identifies nutritional deficiencies before they cause symptoms, tracks metabolic improvements that validate treatment efficacy, flags emerging safety signals requiring dose adjustment or specialist consultation, and helps GLP-1 users understand their biology on a granular level. The boom in at-home testing services has made comprehensive monitoring accessible without frequent clinic visits — a major advance for the nationwide GLP-1 patient population.
At-home blood testing has transformed the monitoring landscape for GLP-1 users — enabling comprehensive panels to be ordered, collected (finger-prick or standard draw at Quest/LabCorp), and reviewed without a traditional doctor's office visit. This accessibility is particularly transformative for users in rural communities, those with limited primary care access, or those on telehealth-only GLP-1 programs.
Everlywell offers an extensive catalog of at-home tests relevant to GLP-1 users: metabolism panels, thyroid function, vitamin D, B12, iron, HbA1c, comprehensive metabolic panels, and inflammation markers. Tests are conducted using finger-prick samples collected at home, with results reviewed by certified physicians and delivered to the Everlywell app within 5–7 business days. Available to customers in all 50 states with direct-to-consumer ordering at moderate price points ($49–$199 per panel). Widely used by the GLP-1 telehealth community nationwide.
Nationwide D2CFunction Health (co-founded by Dr. Mark Hyman and Dr. Peter Attia) offers comprehensive annual blood panels of 100+ biomarkers for $500/year — reviewed by a network of longevity medicine physicians. For GLP-1 users pursuing optimized metabolic health, Function Health's extensive panel includes GLP-1-relevant markers: full lipid particle analysis (LDL-P, HDL-P), advanced metabolic markers (HOMA-IR, fasting insulin), complete micronutrient panels, thyroid antibodies, and comprehensive inflammation markers. Available in most U.S. states through a network of Quest Diagnostics draw sites.
Comprehensive PanelQuest Diagnostics (QuestDirect) and LabCorp's patient portal allow individuals to order laboratory tests directly — without a physician's order — in most U.S. states. For GLP-1 users, this enables self-directed monitoring of HbA1c, comprehensive metabolic panel, CBC, lipid panel, thyroid function, and micronutrient levels without waiting for a clinical appointment. Tests are conducted at thousands of draw sites nationwide. Results are delivered through patient portals and can be shared directly with prescribing clinicians for clinical interpretation.
Walk-In LabsSpectraCell's Micronutrient Test measures the functional intracellular levels of 35+ vitamins, minerals, and antioxidants — the gold standard for identifying deficiencies that serum levels may miss. Particularly relevant for GLP-1 users who have normal serum B12 but intracellular B12 deficiency; or normal serum magnesium but functional magnesium depletion affecting cardiac and muscular function. Available through integrative medicine physicians, functional medicine practitioners, and select telehealth platforms in major cities including New York, Los Angeles, Houston, Chicago, and Miami, with laboratory services nationwide.
Intracellular TestingContinuous glucose monitors (CGMs) have moved beyond their origins in Type 1 diabetes management to become tools for metabolic optimization in GLP-1 users — including non-diabetic patients who want to understand how their diet, exercise, and medication interact to produce their metabolic outcomes.
Levels Health provides CGMs (Dexterity G7 or Libre) to non-diabetic GLP-1 users with a subscription model that includes metabolic coaching and data interpretation. For GLP-1 users without diabetes, CGM data reveals how specific foods trigger blood glucose spikes — enabling highly personalized dietary adjustments that amplify GLP-1 efficacy. Understanding glucose variability and time-in-range metrics helps non-diabetic users optimize their metabolic health. Available to users in most U.S. states through the Levels Health platform.
Non-Diabetic CGMFor GLP-1 users with Type 1 or Type 2 diabetes, prescription CGMs (Dexterity G7, FreeStyle Libre 3, Medtronic Guardian) provide real-time glucose data that is transformative when combined with GLP-1 medications. The combination of GLP-1's glucose-lowering effects and CGM's real-time feedback enables tight glycemic control with minimal hypoglycemia risk. Covered by Medicare and most insurance plans for patients with diabetes meeting CGM criteria. Available through endocrinology practices and durable medical equipment suppliers nationwide.
Diabetic ManagementGLP-1 medications interact with endocrine function in multiple ways: improving thyroid hormone sensitivity, potentially affecting thyroid tumor risk (per animal studies, though not confirmed in humans), and altering sex hormone balance as adipose tissue decreases. Comprehensive thyroid panels (TSH, free T4, free T3, Tg antibodies, TPO antibodies) and hormone panels (testosterone, estradiol, SHBG, cortisol, DHEA-S) are recommended at GLP-1 initiation and annually thereafter. Available through primary care, endocrinology, and direct-order lab services in all 50 states.
Hormonal HealthGut microbiome composition significantly influences GLP-1 receptor expression and the effectiveness of GLP-1 medications — making microbiome testing increasingly relevant for GLP-1 users seeking to optimize outcomes. Viome and Thryve offer at-home stool sample kits that analyze gut bacterial composition and provide personalized dietary and supplement recommendations to optimize the microbiome for GLP-1 efficacy. Emerging research suggests specific probiotic strains can enhance GLP-1 secretion from intestinal L-cells, making microbiome testing a forward-looking optimization tool. Available nationwide through direct-to-consumer ordering.
Microbiome OptimizationComprehensive metabolic monitoring for GLP-1 users is increasingly available beyond the U.S. In Canada, at-home and clinic-based testing panels covering HbA1c, micronutrients, and thyroid function are accessible across Ontario, British Columbia, Alberta, and Quebec through both public health and private labs. European GLP-1 users benefit from well-established national laboratory networks in the UK, Germany, the Netherlands, France, and Scandinavia, and internationally, GLP-1 resources are growing rapidly in Canada across Ontario, British Columbia, Alberta, and Quebec, and in Europe through the UK, Germany, the Netherlands, France, and Scandinavia.
At-home blood testing services ship collection kits to all 50 states and return pre-paid envelopes for sample delivery to CLIA-certified labs. Quest Diagnostics operates over 2,200 patient service centers nationwide, and LabCorp maintains over 2,000 patient service centers — collectively providing in-person blood draw access in virtually every U.S. county, from New York City and Los Angeles to rural communities in South Dakota and Montana. Telehealth providers ordering labs for GLP-1 patients can direct lab work to any nearby facility in their patients' geographic area.